Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

N/AUnknownNCT05173090

University of Liege120 enrolled

Overview

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

120

Conditions

Pain, Acute

Interventions

Ropivacaïne 0,5% for appendectomy or cholecystectomy surgeryDRUG

Visual analog scale 15 min after arrival in the recovery room, then H+4, H+6, H+12, H+24 and one week after the operation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Appendectomy or cholecystectomy surgery Exclusion Criteria: * Allergy to local anesthetics * Intolerance to tramadol HCl * Patient with peritonitis * Pregnant women * Surgery without laparoscopy * Chronic pain before the operation

Outcomes

Primary Outcomes

Patient's pain

The patient's satisfaction was assessed by visual analog scale, ranging from one (worse outcome )to four (better outcome

Time frame: During appendectomy and cholecystectomy surgery

Central Contacts

Benjamin Javillier, MD

CONTACT

+32498573882 javillier.benjamin@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.